Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Laterre

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Pharmacology|November 8, 1988
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, M A Vanisberg, C Laterre, et al.
Brain Research|April 11, 1994
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's diseaseS Holemans, F Javoy-Agid, Y Agid, et al.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
Annals of Neurology|August 1, 1989
Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degenerationA G De Volder, J Francart, C Laterre, et al.
Acta Neurologica Belgica|January 1, 1993
Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degenerationC J Sindic, M Andersson, D Boucquey, et al.
Acta Neurologica Belgica|January 1, 1994
Brain glucose metabolism in postanoxic syndrome due to cardiac arrestA G De Volder, C Michel, J M Guérit, et al.
Acta Neurologica Belgica|January 1, 1990
[Neurological involvement as manifestation of Behçet's disease. 4 clinical case reports]M Gille, C J Sindic, P F Laterre, et al.
European Journal of Epidemiology|September 15, 1999
A retrospective study of Creutzfeldt-Jakob disease in BelgiumP Pals, B Van Everbroeck, R Sciot, et al.
Psychopharmacology|May 5, 1998
Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's diseaseJ Blin, A Ivanoiu, A De Volder, et al.
Brain Research|April 19, 1988
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsyJ M Maloteaux, M A Luabeya, M A Vanisberg, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|November 8, 1988
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, M A Vanisberg, C Laterre, et al.
Brain Research|April 11, 1994
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's diseaseS Holemans, F Javoy-Agid, Y Agid, et al.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
Annals of Neurology|August 1, 1989
Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degenerationA G De Volder, J Francart, C Laterre, et al.
Acta Neurologica Belgica|January 1, 1993
Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degenerationC J Sindic, M Andersson, D Boucquey, et al.
Acta Neurologica Belgica|January 1, 1994
Brain glucose metabolism in postanoxic syndrome due to cardiac arrestA G De Volder, C Michel, J M Guérit, et al.
Acta Neurologica Belgica|January 1, 1990
[Neurological involvement as manifestation of Behçet's disease. 4 clinical case reports]M Gille, C J Sindic, P F Laterre, et al.
European Journal of Epidemiology|September 15, 1999
A retrospective study of Creutzfeldt-Jakob disease in BelgiumP Pals, B Van Everbroeck, R Sciot, et al.
Psychopharmacology|May 5, 1998
Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's diseaseJ Blin, A Ivanoiu, A De Volder, et al.
Brain Research|April 19, 1988
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsyJ M Maloteaux, M A Luabeya, M A Vanisberg, et al.
Pageof 11